WO2023281981A1 - 微生物処理用液及び微生物処理用液の製造方法 - Google Patents
微生物処理用液及び微生物処理用液の製造方法 Download PDFInfo
- Publication number
- WO2023281981A1 WO2023281981A1 PCT/JP2022/023446 JP2022023446W WO2023281981A1 WO 2023281981 A1 WO2023281981 A1 WO 2023281981A1 JP 2022023446 W JP2022023446 W JP 2022023446W WO 2023281981 A1 WO2023281981 A1 WO 2023281981A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- microbial treatment
- concentration
- quantum
- acid
- Prior art date
Links
- 230000000813 microbial effect Effects 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 156
- 239000007788 liquid Substances 0.000 claims abstract description 85
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims abstract description 66
- 230000002378 acidificating effect Effects 0.000 claims abstract description 65
- 230000002093 peripheral effect Effects 0.000 claims abstract description 9
- 229910000963 austenitic stainless steel Inorganic materials 0.000 claims abstract description 6
- 229910001105 martensitic stainless steel Inorganic materials 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims description 9
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 150000003566 thiocarboxylic acids Chemical class 0.000 claims description 2
- 239000012634 fragment Substances 0.000 abstract description 5
- 238000010438 heat treatment Methods 0.000 abstract description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 37
- 239000000460 chlorine Substances 0.000 description 37
- 229910052801 chlorine Inorganic materials 0.000 description 37
- 238000012360 testing method Methods 0.000 description 21
- 241000588724 Escherichia coli Species 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 230000002779 inactivation Effects 0.000 description 9
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 208000001528 Coronaviridae Infections Diseases 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000000415 inactivating effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000001384 succinic acid Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- QNGVNLMMEQUVQK-UHFFFAOYSA-N 4-n,4-n-diethylbenzene-1,4-diamine Chemical compound CCN(CC)C1=CC=C(N)C=C1 QNGVNLMMEQUVQK-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003011 anion exchange membrane Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910001504 inorganic chloride Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009372 pisciculture Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/08—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
Definitions
- the present invention relates to a microbial treatment liquid and a method for producing the microbial treatment liquid.
- Patent Document 1 discloses a liquid treatment apparatus comprising a container having a liquid inlet and an outlet, and a plurality of pieces placed in the container.
- the elemental piece is made of austenitic stainless steel or martensitic stainless steel, has a regular hexagonal prism shape, and has a hole penetrating the bottom surface and the surface of the elemental piece, It is an elemental piece obtained by subjecting a elemental piece having a hole with a circular cross section and a helical groove on the inner peripheral surface of the hole, which circles the inner peripheral surface for one or more rounds, to heat treatment.
- the elemental pieces are arranged so that the central axes of the elemental pieces (meaning the central axes that are parallel to the six side faces of the regular hexagonal prism and perpendicular to both end faces of the regular hexagonal prism) are parallel to each other, and An array is held, and the arrayed pieces are positioned between the inlet and the outlet.
- Quantum water is said to have effects such as hydrogen generation, sterilization, deodorization, lactic acid bacteria growth, surface activity, chlorine detoxification, and enzyme activation.
- Patent Document 2 discloses an electrolytic device that includes an electrolytic cell, a first line, and a second line.
- the electrolytic cell comprises an anode chamber having an anode electrode, an intermediate chamber separated from the anode chamber by an anion exchange membrane, inorganic chloride particles accommodated in the intermediate chamber, and the intermediate chamber separated from the cation exchange membrane. and a cathode chamber having a cathode electrode.
- a first line draws hypochlorous acid water from the anode chamber and a second line draws alkaline water from the cathode chamber.
- hypochlorous acid water generated in the electrolytic cell and the hypochlorous acid water generated by applying Plasmacluster technology, which is one of the "weak charge technology" are acidic, and hydrochloric acid is No use, safe, high chlorine concentration.
- Acidic hypochlorous acid water includes strongly acidic hypochlorous acid water, weakly acidic hypochlorous acid water, and slightly acidic hypochlorous acid water.
- quantum water has a certain amount of sterilization power, there is the problem that it cannot inactivate the virus of the new coronavirus infection.
- acidic hypochlorous acid water can inactivate the virus of the new coronavirus infection, but if left for a long time, the chlorine concentration of acidic hypochlorous acid water will decrease and the sterilization power will be lost. There is a problem.
- the present invention has been made to solve the above-mentioned problems, and is capable of maintaining the sterilizing power of acidic hypochlorous acid water for a long period of time. intended to provide
- the microbial treatment liquid according to the present invention contains acidic hypochlorous acid water and quantum water.
- the acidic hypochlorous acid water has a concentration of 0.5% to 5.0% by weight with respect to the total microbial treatment liquid
- the quantum water has a concentration of 90.0% by weight to 90.0% by weight with respect to the total microbial treatment liquid. It has a concentration of 99.5% by weight.
- the quantum water is water passed through a quantum water converter, and the quantum water converter comprises a container having an inlet and an outlet for the water, and a plurality of pieces placed in the container.
- the liquid processing apparatus wherein the piece has a regular hexagonal prism shape made of austenitic stainless steel or martensitic stainless steel, and has a hole with a circular cross section penetrating the bottom surface and the surface of the piece, And, it is obtained by heat-treating a material having a spiral groove that encircles the inner peripheral surface of the hole one or more times, and the elemental piece is parallel to six side surfaces of the regular hexagonal prism, and is parallel to both end surfaces of the regular hexagonal prism. They are positioned between the inlet and the outlet such that their orthogonal central axes are aligned parallel to each other.
- the method for producing a microbial treatment liquid according to the present invention includes a mixing step, wherein the mixing step includes acidic hypochlorous acid at a concentration of 0.5% to 5.0% by weight with respect to the total microbial treatment liquid. Acidic water is mixed with quantum water having a concentration of 90.0% to 99.5% by weight with respect to the total microbial treatment liquid.
- FIG. 1 is a conceptual diagram of a microbial treatment liquid according to the present invention
- FIG. 1 is a table of E. coli inactivation test results in Example 1, Reference Example 1, and Comparative Example 1-2.
- 1 is a graph showing the results of an E. coli inactivation test in Example 1, Reference Example 1, and Comparative Example 1-2.
- 1 is photographs of test tubes after one month in Example 1, Reference Example 1, and Comparative Example 1-2.
- the inventor of the present invention has been dealing with acidic hypochlorous acid water and quantum water for many years, and has pondered the problem that the sterilizing power of acidic hypochlorous acid water is lost in a short period of time.
- quantum water has been recognized to have a wide variety of effects, and the inventor thought that it would contribute to the long-term sterilization of acidic hypochlorous acid water, and used acidic hypochlorous acid water.
- quantum water When diluted with quantum water, it was surprisingly discovered that the sterilizing power of acidic hypochlorous acid water was maintained for a long period of time. Accordingly, the inventors completed the present invention based on the following examples.
- the microbial treatment liquid according to the present invention contains acidic hypochlorous acid water with a concentration of 0.5% by weight to 5.0% by weight with respect to the total microbial treatment liquid, and Quantum water having a concentration of 90.0% to 99.5% by weight with respect to the microbial treatment liquid.
- Quantum water is water passed through a quantum water converter, and the quantum water converter is a liquid consisting of a container 22 having a water inlet and a water outlet, and a plurality of elementary pieces 1 installed in the container 22.
- the element having a spiral groove that goes around one or more rounds of the inner peripheral surface of the hole is subjected to heat treatment, and the elemental piece 1 is parallel to the six side surfaces of the regular hexagonal prism and perpendicular to both end faces of the regular hexagonal prism.
- Patent Document 1 of International Publication No. 03/055591.
- Patent Document 1 like the present invention, describes the diluting water of acidic hypochlorous acid water. It is not stated that quantum water is effective as
- the method for producing a microbial treatment liquid according to the present invention includes a mixing step, wherein the mixing step includes acidic hypochlorous acid at a concentration of 0.5% to 5.0% by weight with respect to the total microbial treatment liquid. Acidic water is mixed with quantum water having a concentration of 90.0% to 99.5% by weight with respect to the total microbial treatment liquid.
- the microbial treatment liquid according to the present invention has an antiviral effect and a deodorant effect, it can be safely used while inactivating microorganisms even in narrow spaces such as inside cars and buildings and at nursing care sites. It can be used safely.
- the quantum water enables the residual chlorine concentration to be maintained for a long period of time.
- the type of acidic hypochlorous acid water is not particularly limited, but for example, any one of strongly acidic hypochlorous acid water, weakly acidic hypochlorous acid water, slightly acidic hypochlorous acid water, or a combination thereof can be mentioned.
- strongly acidic hypochlorous acid water and weakly acidic hypochlorous acid water are generated by electrolyzing sodium chloride aqueous solution in an electrolytic cell with a diaphragm, so sodium chloride aqueous solution with high safety is used. Therefore, the strongly acidic hypochlorous acid water and the weakly acidic hypochlorous acid water do not contain hydrochloric acid.
- slightly acidic hypochlorous acid water is generated by electrolyzing hydrochloric acid or a mixed solution of hydrochloric acid and sodium chloride aqueous solution without a diaphragm, so that hydrochloric acid is used, so slightly acidic hypochlorous acid water may contain hydrochloric acid. Therefore, in the present invention, from the viewpoint of safety, it is preferable to employ either strongly acidic hypochlorous acid water or weakly acidic hypochlorous acid water or a combination thereof.
- the residual chlorine concentration of the acidic hypochlorous acid water is not particularly limited, but for example, it is preferably within the range of 500 ppm to 3000 ppm, more preferably within the range of 1000 ppm to 2000 ppm.
- the acidic hypochlorous acid water corresponds to the undiluted solution.
- the pH of the acidic hypochlorous acid water is not particularly limited as long as the acidic hypochlorous acid water is acidic, but is preferably within the range of 4.0 to 5.0, for example.
- the concentration of the acidic hypochlorous acid water is not particularly limited as long as it is within the range of 0.5% by weight to 5.0% by weight with respect to the total microbial treatment liquid, but for example, 0.5% by weight % to 2.0% by weight, more preferably 0.5% to 1.0% by weight.
- the quantum water is not particularly limited as long as it is water that has passed through a quantum water converter, and the type of water may be tap water, distilled water, ion-exchanged water, purified water, or the like. Further, the quantum water may be water that has been passed through the quantum water converter for the first time, or water that has been repeatedly passed through the quantum water converter.
- quantum water converter is not particularly limited, for example, a commercially available quantum water converter with the product name ⁇ G7 (New Seven) can be mentioned.
- the size of the quantum water converter is typically in the range of 20mm to 300mm in diameter and 50mm to 400mm in stroke.
- the quantum water converter may be one or a plurality of connected ones.
- the quantum water converter comprises a container 22, a bottom plate 23, and a top plate 25, which are made of thin stainless steel plates.
- the bottom plate 23 and the top plate 25 are provided with a large number of through holes with a diameter of 3 mm. A part of the through hole of the upper plate 25 is omitted in the drawing.
- the bottom plate 23 is fixed to the bottom portion of the container 22 by bending a peripheral portion 24 and partially welding the portion 24 .
- a predetermined number (for example, 19) of elemental pieces 1 are arranged in an OHA on the bottom plate 24 .
- OHA Ortho-Hexagonal Arrangement
- This predetermined number of segments 1 constitute one stage, and these are stacked in predetermined stages (for example, nine stages). Note that the second to ninth stages are omitted. If the first stage consists of 19 segments 1 and the same stage exists up to the ninth stage, the total number of segments 1 is 171.
- the OHAs in each stage are stacked with the centers of the concentric circles substantially aligned vertically. Therefore, the central axis of the piece 1 arranged at the central point of each stage forms substantially one virtual straight line.
- the upper plate 25 is fixed to the upper surface of the container 22 by bending the peripheral portion 26 and partially welding the portion 26 .
- the length of one side of a regular hexagonal prism is, for example, 15 mm, the height is 31 mm, and the distance between the top plate 25 and the bottom plate 23 is 22 mm.
- 19 fragments 1 are stored as OHA. The same applies to the second to ninth stages. Sandwiched between the side plate of the container, the bottom plate 23 and the top plate 25, the movement of the elemental piece 1 is restricted and the arrangement of the OHA is maintained.
- the concentration of quantum water is not particularly limited as long as it is within the range of 90.0% by weight to 99.5% by weight with respect to the total microbial treatment liquid. It is preferably in the range of 5% by weight, more preferably in the range of 97.0% to 99.5% by weight.
- the pH of the quantum water is not particularly limited, but is preferably in the range of 6.5 to 7.5, for example.
- the ratio of the concentration of acidic hypochlorous acid water and the concentration of quantum water is not particularly limited, but for example, it is preferably in the range of 1:10 to 1:150, and 1:30 to 1:100. It is more preferable that it is within the range.
- the concentration of residual chlorine in the microbial treatment solution is not particularly limited, but is preferably within the range of 5 ppm to 30 ppm, more preferably within the range of 10 ppm to 20 ppm.
- the pH of the microbial treatment liquid is preferably within the range of 5.0 to 7.0, for example.
- additives may be added to the microbial treatment liquid.
- Other additives for example, selected from the group consisting of formic acid, acetic acid, propionic acid, sulfonic acid, sulfinic acid, thiocarboxylic acid, citric acid, malic acid, tartaric acid, oxalic acid, succinic acid, lactic acid and combinations thereof
- Mention may be made of organic acids.
- organic acids By adding an organic acid, it contributes to maintaining the concentration of residual chlorine in the liquid for microbial treatment, and it becomes possible to store the liquid for a long period of time while maintaining its sterilizing power.
- succinic acid is more preferable.
- the microbial treatment liquid can be used in any way.
- the microbial treatment liquid may be directly sprayed or applied onto the object. Further, the microbial treatment liquid may be put into a humidifier to make the microbial treatment liquid into a mist to sterilize the space.
- the concentration of residual chlorine in the mist-like microbial treatment liquid is 5 ppm or less, and there is no problem with safety.
- the present invention is effective as a microbial treatment liquid that is safe and highly effective in inactivating viruses and the like. It is applicable to all fields of the pet industry and manufacturing industry.
- the present invention can be used to clean precision instruments that cannot use alcohol in the manufacturing industry, such as fish farming, pig farms, and cattle farms in the livestock industry, and pet breeding farms in the pet industry. It can be used safely and for a long time even for cleaning specially processed glass that cannot be cleaned, and can be used for various purposes.
- Example 1 Acidic hypochlorous acid water and quantum water were prepared.
- the residual chlorine concentration of the acidic hypochlorous acid water was 1300 ppm
- the pH of the acidic hypochlorous acid water was 4.0 to 5.0.
- Quantum water was produced by passing distilled water through a commercially available quantum water converter (manufactured by Wellness Co., Ltd.) with the product name ⁇ G7 (NewG7).
- Example 1 was prepared by mixing 100 parts by weight of quantum water with 1 part by weight of acidic hypochlorous acid water.
- the concentration of residual chlorine in the liquid for microbial treatment of Example 1 was 13 ppm
- the pH of the liquid for microbial treatment of Example 1 was 6.5.
- Comparative Example 1 was prepared in the same manner as in Example 1, except that the quantum water was changed to distilled water.
- Example 2 The elemental quantum water used in Example 1 was designated as Comparative Example 2.
- ⁇ Evaluation method for microbial treatment liquid> (1) Inactivation test for E. coli After putting 3 ml of each of the microbial treatment solutions of Example 1, Reference Example 1, and Comparative Example 1-2 into a test tube, the number of bacteria was 6.3 ⁇ 10 7 CFU/100 ml. 10 mL of the E. coli solution was added using a digital pipette, the microbial treatment solution and the E. coli solution were allowed to react, and the test tube was allowed to stand. Next, the reaction solution was sampled after a predetermined standing time from immediately after the addition, and the number of viable E. coli cells (CFU/100 ml) was measured using the sampled reaction solution. The predetermined leaving time is set to 1 minute, 5 minutes, 60 minutes (1 hour), 1,440 minutes (24 hours), and 43,200 minutes (1 month 30 days). It was confirmed whether the bactericidal power was maintained over a period of time.
- FIG. 2 shows a table of E. coli inactivation test results in Example 1, Reference Example 1, and Comparative Example 1-2.
- FIG. 3 shows a graph of the E. coli inactivation test results in Example 1, Reference Example 1, and Comparative Example 1-2.
- E. coli could not be inactivated.
- Comparative Example 1 although E. coli could be inactivated, the viable cell count of 8.8 ⁇ 10 6 CFU/100 ml was measured when the standing time was 43,200 minutes, indicating that E. coli could not be inactivated. I found out.
- Example 1 even if the standing time was 43,200 minutes, the viable count was less than 1.0 ⁇ 10 2 CFU/100 ml, and it was possible to continuously inactivate E. coli. . That is, in Example 1, it was found that the sterilizing power of the acidic hypochlorous acid water was maintained even after one month of standing time.
- FIG. 4 is a photograph of test tubes after one month in Example 1, Reference Example 1, and Comparative Example 1-2. As shown in FIG. 4, in Reference Example 1 and Comparative Example 2, since there was no residual chlorine concentration, the film remained transparent, but in Comparative Example 1, it was found to be slightly colored. On the other hand, in Example 1, compared with Comparative Example 1, it was found that the coloring was strong and the residual chlorine concentration was high. Here, when the residual chlorine concentration was measured for Example 1, it was found that the residual chlorine concentration was 13 ppm, which was equivalent to the initial residual chlorine concentration, and that the residual chlorine concentration was maintained over a long period of time.
- Example 2 was prepared in the same manner as in Example 1, except that 1 part by weight of succinic acid was further added.
- the residual chlorine concentration of the microbial treatment liquid of Example 2 was 13 ppm, and the pH of the microbial treatment liquid of Example 1 was 6.5.
- Example 2 an inactivation test for E. coli and a confirmation test for residual chlorine concentration were performed. It was found to continuously inactivate E. coli with a viable cell count of less than x10 2 CFU/100 ml. Moreover, when the residual chlorine concentration was measured, it was found to be equivalent to 13 ppm, indicating that the residual chlorine concentration was maintained over a long period of time.
- Example 3 an inactivation test for E. coli and a confirmation test for residual chlorine concentration were performed. , with a viable cell count of less than 1.0 ⁇ 10 2 CFU/100 ml, and was found to continuously inactivate E. coli. Further, when the residual chlorine concentration was measured, it was found to be equivalent to 26 ppm in Example 3 and equivalent to 43 ppm in Example 4, indicating that the residual chlorine concentration was maintained over a long period of time.
- Example 5-7 an inactivation test for E. coli and a confirmation test for residual chlorine concentration were performed in the same manner. , with a viable cell count of less than 1.0 ⁇ 10 2 CFU/100 ml, and was found to continuously inactivate E. coli. In addition, when the residual chlorine concentration was measured, it was found that the concentration of residual chlorine in Examples 5-7 was the same as the initial concentration, and the residual chlorine concentration was maintained over a long period of time.
- the microbial treatment liquid and the method for producing the microbial treatment liquid according to the present invention can be used in the hygiene industry, the medical industry, the nursing industry, the transportation industry, the service industry, the retail industry, the livestock industry, the pet industry, and the manufacturing industry. It is applicable to all fields and is effective as a microbial treatment liquid and a method for producing a microbial treatment liquid that can maintain the sterilizing power of acidic hypochlorous acid water for a long period of time.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Inorganic Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
Abstract
Description
酸性次亜塩素酸水と量子水とを用意した。ここで、酸性次亜塩素酸水の残留塩素濃度は、1300ppmであり、酸性次亜塩素酸水のpHは、4.0~5.0であった。又、量子水は、市販の製品名νG7(ニュージーセブン)の量子水転換器(株式会社ウエルネス製)に蒸留水を通すことで生成した。そして、1重量部の酸性次亜塩素酸水に100重量部の量子水を混合することで作成した微生物処理用液を実施例1とした。実施例1の微生物処理用液の残留塩素濃度は、13ppmであり、実施例1の微生物処理用液のpHは、6.5であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+100)=0.99重量%であり、全微生物処理用液に対する量子水の濃度は、100/(1+100)=99.01重量%である。
蒸留水単体を参考例1とした。
実施例1において、量子水を蒸留水に変更したこと以外は、実施例1と同様にして作成した微生物処理用液を比較例1とした。
実施例1において使用した量子水単体を比較例2とした。
(1)大腸菌に対する不活化試験
実施例1、参考例1、比較例1-2のそれぞれの微生物処理用液を試験管に3ml入れた後に、菌数が6.3×107CFU/100mlの大腸菌液をデジタルピペットで10mL添加して、微生物処理用液と大腸菌液とを反応させて、試験管を放置した。次に、添加直後から所定の放置時間が経過後の反応液を採取して、採取した反応液を用いて大腸菌の生菌数(CFU/100ml)を計測した。所定の放置時間は、1分間、5分間、60分間(1時間)、1,440分間(24時間)、43,200分間(1ヶ月=30日間)に設定し、微生物処理用液が長期的にわたって殺菌力を維持するか否かを確認した。
実施例1、参考例1、比較例1-2のそれぞれの微生物処理用液を試験管に3ml入れた後に、市販の残留塩素検出試薬(DPD溶液、N,N-ジエチルパラフェニレンジアミン溶液)をデジタルピペットで10mL添加して、微生物処理用液と残留塩素検出試薬とを反応させて、試験管を放置した。添加直後から43,200分間(1ヶ月=30日間)が経過後に、染色具合を確認した。又、発色が良好な試験管については、540nmの吸光度を測定し、検量線を用いて、残留塩素濃度を測定した。
(1)大腸菌に対する不活化試験
図2は、実施例1、参考例1、比較例1-2における大腸菌の不活化試験結果の表を示す。図3は、実施例1、参考例1、比較例1-2における大腸菌の不活化試験結果のグラフを示す。図2-図3に示すように、参考例1と比較例2では、大腸菌を不活化することは出来なかった。比較例1では、大腸菌を不活化することが出来たものの、放置時間が43200分間では、8.8×106CFU/100mlの生菌数が計測され、大腸菌を不活化することが出来ないことが分かった。一方、実施例1では、放置時間が43,200分間であっても、1.0×102CFU/100ml未満の生菌数であり、大腸菌を継続して不活化することが可能であった。つまり、実施例1では、放置時間が1ヶ月経過しても、酸性次亜塩素酸水の殺菌力が持続されることが分かった。
図4は、実施例1、参考例1、比較例1-2における1ヶ月経過後の試験管の写真である。図4に示すように、参考例1と比較例2では、残留塩素濃度が無いため、透明なままであるが、比較例1では、若干発色していることが分かった。一方、実施例1では、比較例1と比較して、発色が強く、残留塩素濃度が高いことが分かった。ここで、実施例1について、残留塩素濃度を測定したところ、13ppmと当初と同等の残留塩素濃度であり、残留塩素濃度が長期間にわたって持続されることが分かった。
実施例1において、1重量部のコハク酸を更に添加したこと以外は、実施例1と同様にして作成した微生物処理用液を実施例2とした。実施例2の微生物処理用液の残留塩素濃度は、13ppmであり、実施例1の微生物処理用液のpHは、6.5であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+100+1)=0.98重量%であり、全微生物処理用液に対する量子水の濃度は、100/(1+100+1)=98.04重量%であり、全微生物処理用液に対するコハク酸の濃度は、1/(1+100+1)=0.98重量%である。
実施例1において、1重量部の酸性次亜塩素酸水に50重量部の量子水を混合することで作成したこと以外は、実施例1と同様にして作成した微生物処理用液を実施例3とした。実施例3の微生物処理用液の残留塩素濃度は、26ppmであり、実施例3の微生物処理用液のpHは、6.0であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+50)=1.96重量%であり、全微生物処理用液に対する量子水の濃度は、50/(1+50)=98.04重量%である。
実施例1において、1重量部の酸性次亜塩素酸水に30重量部の量子水を混合することで作成したこと以外は、実施例1と同様にして作成した微生物処理用液を実施例4とした。実施例4の微生物処理用液の残留塩素濃度は、43ppmであり、実施例4の微生物処理用液のpHは、5.8であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+30)=3.22重量%であり、全微生物処理用液に対する量子水の濃度は、30/(1+30)=96.78重量%である。
実施例1において、1重量部の酸性次亜塩素酸水に199重量部の量子水を混合することで作成したこと以外は、実施例1と同様にして作成した微生物処理用液を実施例5とした。実施例5の微生物処理用液の残留塩素濃度は、10ppmであり、実施例5の微生物処理用液のpHは、6.7であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+199)=0.50重量%であり、全微生物処理用液に対する量子水の濃度は、199/(1+199)=99.50重量%である。
実施例1において、1重量部の酸性次亜塩素酸水に19重量部の量子水を混合することで作成したこと以外は、実施例1と同様にして作成した微生物処理用液を実施例6とした。実施例6の微生物処理用液の残留塩素濃度は、50ppmであり、実施例6の微生物処理用液のpHは、5.5であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+19)=5.00重量%であり、全微生物処理用液に対する量子水の濃度は、19/(1+19)=95.00重量%である。
実施例1において、1重量部の酸性次亜塩素酸水に18重量部の量子水と1重量部の香料とを混合することで作成したこと以外は、実施例1と同様にして作成した微生物処理用液を実施例7とした。実施例7の微生物処理用液の残留塩素濃度は、50ppmであり、実施例7の微生物処理用液のpHは、5.4であった。この場合、全微生物処理用液に対する酸性次亜塩素酸水の濃度は、1/(1+18+1)=5.00重量%であり、全微生物処理用液に対する量子水の濃度は、18/(1+18+1)=90.00重量%であり、全微生物処理用液に対する香料の濃度は、1/(1+18+1)=5.00重量%である。
Claims (4)
- 全微生物処理用液に対して0.5重量%~5.0重量%の濃度の酸性次亜塩素酸水と、
全微生物処理用液に対して90.0重量%~99.5重量%の濃度の量子水と、
を含有し、
前記量子水は、量子水転換器に通した水であり、
前記量子水転換器は、前記水の流入口と流出口を有する容器と、前記容器の中に設置された複数の素片からなる液体処理装置であり、前記素片は、オーステナイト系ステンレス鋼又はマルテンサイト系ステンレス鋼を材質とした正六角柱状であり、前記素片の底面と表面を貫通する断面が円形の穴を有し、且つ、前記穴の内周面を一周以上周回する螺旋溝を有するものに加熱処理を施したものであり、前記素片は、正六角柱の6つの側面に平行であり、正六角柱の両端面と直交する中心軸が相互に平行になるように配列されるように、前記流入口と前記流出口の間に位置づけられている、
微生物処理用液。 - 蟻酸、酢酸、プロピオン酸、スルホン酸、スルフィン酸、チオカルボン酸、クエン酸、リンゴ酸、酒石酸、シュウ酸、コハク酸、乳酸及びそれらの組み合わせからなる群から選ばれた有機酸
を更に含有する、
請求項1に記載の微生物処理用液。 - 前記酸性次亜塩素酸水の濃度と前記量子水の濃度との比率は、1:10~1:150の範囲内である、
請求項1に記載の微生物処理用液。 - 全微生物処理用液に対して0.5重量%~5.0重量%の濃度の酸性次亜塩素酸水と、全微生物処理用液に対して90.0重量%~99.5重量%の濃度の量子水と、を混合する混合工程
を備え、
前記量子水は、量子水転換器に通した水であり、
前記量子水転換器は、前記水の流入口と流出口を有する容器と、前記容器の中に設置された複数の素片からなる液体処理装置であり、前記素片は、オーステナイト系ステンレス鋼又はマルテンサイト系ステンレス鋼を材質とした正六角柱状であり、前記素片の底面と表面を貫通する断面が円形の穴を有し、且つ、前記穴の内周面を一周以上周回する螺旋溝を有するものに加熱処理を施したものであり、前記素片は、正六角柱の6つの側面に平行であり、正六角柱の両端面と直交する中心軸が相互に平行になるように配列されるように、前記流入口と前記流出口の間に位置づけられている、
微生物処理用液の製造方法。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2022306199A AU2022306199A1 (en) | 2021-07-06 | 2022-06-10 | Microbial treatment solution and method of producing microbial treatment solution |
JP2023511772A JP7323147B2 (ja) | 2021-07-06 | 2022-06-10 | 微生物処理用液及び微生物処理用液の製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021-132083 | 2021-07-06 | ||
JP2021132083 | 2021-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023281981A1 true WO2023281981A1 (ja) | 2023-01-12 |
Family
ID=84800544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/023446 WO2023281981A1 (ja) | 2021-07-06 | 2022-06-10 | 微生物処理用液及び微生物処理用液の製造方法 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7323147B2 (ja) |
AU (1) | AU2022306199A1 (ja) |
WO (1) | WO2023281981A1 (ja) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10182325A (ja) * | 1996-12-20 | 1998-07-07 | Cytec Kk | 次亜塩素酸ナトリウムの殺菌力増強装置 |
JPH11228316A (ja) * | 1998-02-19 | 1999-08-24 | Clean Chemical Kk | 殺菌消毒用製剤 |
JP2002249407A (ja) * | 2001-02-22 | 2002-09-06 | Tsukasa Denshi Kk | 殺菌消毒剤 |
WO2003055591A1 (fr) * | 2001-12-25 | 2003-07-10 | Wellness Co., Ltd. | Convertisseur de champ et dispositif de traitement de fluides utilisant ce convertisseur |
WO2006057311A1 (ja) * | 2004-11-24 | 2006-06-01 | Maruishi Pharmaceutical Co., Ltd. | 次亜塩素酸系殺菌剤組成物 |
JP2011153095A (ja) * | 2010-01-27 | 2011-08-11 | Pureson Corp | 消毒液及びその製造方法 |
JP2014009227A (ja) * | 2012-07-03 | 2014-01-20 | Pureson Corp | 消毒液の製造方法 |
JP2019155304A (ja) * | 2018-03-15 | 2019-09-19 | 株式会社ウエルネス | 水処理装置 |
-
2022
- 2022-06-10 WO PCT/JP2022/023446 patent/WO2023281981A1/ja active Application Filing
- 2022-06-10 AU AU2022306199A patent/AU2022306199A1/en active Pending
- 2022-06-10 JP JP2023511772A patent/JP7323147B2/ja active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10182325A (ja) * | 1996-12-20 | 1998-07-07 | Cytec Kk | 次亜塩素酸ナトリウムの殺菌力増強装置 |
JPH11228316A (ja) * | 1998-02-19 | 1999-08-24 | Clean Chemical Kk | 殺菌消毒用製剤 |
JP2002249407A (ja) * | 2001-02-22 | 2002-09-06 | Tsukasa Denshi Kk | 殺菌消毒剤 |
WO2003055591A1 (fr) * | 2001-12-25 | 2003-07-10 | Wellness Co., Ltd. | Convertisseur de champ et dispositif de traitement de fluides utilisant ce convertisseur |
WO2006057311A1 (ja) * | 2004-11-24 | 2006-06-01 | Maruishi Pharmaceutical Co., Ltd. | 次亜塩素酸系殺菌剤組成物 |
JP2011153095A (ja) * | 2010-01-27 | 2011-08-11 | Pureson Corp | 消毒液及びその製造方法 |
JP2014009227A (ja) * | 2012-07-03 | 2014-01-20 | Pureson Corp | 消毒液の製造方法 |
JP2019155304A (ja) * | 2018-03-15 | 2019-09-19 | 株式会社ウエルネス | 水処理装置 |
Also Published As
Publication number | Publication date |
---|---|
AU2022306199A1 (en) | 2024-02-15 |
JP7323147B2 (ja) | 2023-08-08 |
JPWO2023281981A1 (ja) | 2023-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yan et al. | New clinical applications of electrolyzed water: a review | |
KR20190115372A (ko) | 순수한 이산화염소 수용액의 제조방법 및 그 제조장치 | |
Farah et al. | Electrolyzed water generated on-site as a promising disinfectant in the dental office during the COVID-19 pandemic | |
EP2456722B1 (en) | Water decontamination system | |
CN110862130A (zh) | 一种水消毒和降解水中碘代造影剂的方法 | |
WO2023281981A1 (ja) | 微生物処理用液及び微生物処理用液の製造方法 | |
JPWO2019107510A1 (ja) | 次亜塩素酸を含む抗微生物剤 | |
US6331514B1 (en) | Sterilizing and disinfecting compound | |
JP6243482B2 (ja) | 病原性微生物の不活性化方法 | |
JP2024518673A (ja) | 電気活性化超酸化水及びその合成方法 | |
CN109526982A (zh) | 一种低pH的抗微生物溶液及其应用 | |
CN113197199A (zh) | 一种器械消毒液及其制备方法和应用 | |
Ahari et al. | The Effect of Gamma (γ) Irradiation to inactivate Escherichia coli in contaminated water | |
WO2020019047A1 (pt) | Tecnologia de produção de agente desinfectante para neutralização de vírus, bactérias e demais microrganismos | |
CN113170801A (zh) | 一种消毒液及其制备方法和应用 | |
JP2008214297A (ja) | 抗ウイルス剤 | |
JP2009142367A (ja) | 消毒方法 | |
CN1703148B (zh) | 有机化合物和金属离子协同消毒和净化的体系及制备方法 | |
JPH01254287A (ja) | 循環水系の細菌発生防止法 | |
KR101140147B1 (ko) | 소독 및 탈취용 조성물 및 이를 포함하는 사료용 소독제 | |
Bocklagea et al. | Evaluation of Hypochlorous Acid Fogging: An Alternative Disinfection Method | |
Sharma et al. | Water: Disinfection & Microbiological Analysis | |
CN113180056B (zh) | 次氯酸消毒液 | |
Baguindoc | EVALUATION OF POTENTIAL SANITATION AND DISINFECTION MEASURES APPLICABLE FOR ANTIBIOTIC-FREE PIG PRODUCTION | |
JPWO2023281981A5 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2023511772 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22835558 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: AU2022306199 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022306199 Country of ref document: AU Date of ref document: 20220610 Kind code of ref document: A |